PepJunkie Home of the Peptonauts
More

Peptide Atlas · Peptide

Relamorelin

Relamorelin (RM-131) is a selective ghrelin receptor agonist; in a 12-week phase 2B study in 393 people with diabetic gastroparesis, vomiting frequency fell 75% from baseline, but not significantly more than on placebo.

What the evidence says

six tiers, never blended

emerging — human data exists, and it is thin or contested

every claim resolves to its source

All 2 citations resolve to their original source. · 0 posts naming it, 0 members counted once each.

No protocol has enough distinct humans behind it to be a protocol. One person saying it twice is still one person.

Negative findings

failure is information

Nobody has filed a failure yet. Failures are information; this list is waiting for an honest one.